Exhibit 23.2

               Consent of Ernst & Young LLP, Independent Auditors

We consent to the reference to our firm under the captions "Experts" and
"Selected Consolidated Financial Data" in Amendment No. 1 to the Registration
Statement (Form S-3, No. 333-33268) and related Prospectus of Cell
Therapeutics, Inc. for the registration of 3,450,000 shares of its common stock
and to the incorporation by reference therein of our report dated February 25,
2000, with respect to the consolidated financial statements of Cell
Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended
December 31, 1999, filed with the Securities and Exchange Commission.

Ernst & Young LLP

Seattle, Washington

March 30, 2000